Status:
TERMINATED
A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Prostate Cancer
Quality of Life
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
The investigators propose a prospective study to assess recovery of urinary and sexual function by nerve sparing techniques after radical prostatectomy.
Detailed Description
Subjects will be randomized in a 1:1 ratio to Retzius nerve sparing versus non-Retzius nerve sparing to compare cancer outcomes and urinary/sexual outcomes following radical prostatectomy. Using the R...
Eligibility Criteria
Inclusion
- clinically localized prostate cancer
- able to read and speak English or Spanish
- no previous history of head injury, dementia or psychiatric illness
- no other concurrent cancer
- estimated life expectancy of 10 years or more
- biopsy proven prostate cancer
Exclusion
- evidence of metastases
- Prostate specific antigen (PSA) greater than 30 ng/mL
- previous major pelvic surgery
- diagnosis of another malignancy within the past 5 years, with the exception of non-melanoma skin cancer
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04393831
Start Date
June 15 2021
End Date
September 15 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065